0001681171-16-000002.txt : 20160808
0001681171-16-000002.hdr.sgml : 20160808
20160808204805
ACCESSION NUMBER: 0001681171-16-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160727
FILED AS OF DATE: 20160808
DATE AS OF CHANGE: 20160808
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KAVANAGH SARAH B
CENTRAL INDEX KEY: 0001681171
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 161815816
MAIL ADDRESS:
STREET 1: 400 SOMERSET CORPORATE BOULEVARD
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2016-07-27
0
0000885590
Valeant Pharmaceuticals International, Inc.
VRX
0001681171
KAVANAGH SARAH B
2150 ST. ELZEAR BLVD.
LAVAL
A8
H7L 4A8
QUEBEC, CANADA
1
0
0
0
Common Stock, no par value
2016-07-27
4
A
0
14458
0
A
14458
D
Represents Restricted Share Units ("RSUs") representing a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc.
Prorated annual grant of restricted stock units equal to $339,640. Pricing is based on the closing price of registrant common stock on the date of grant.
Robert Chai-Onn for Sarah B. Kavanagh
2016-08-08